New therapies prolong the lives of AIDS patients

The report, published in the British journal Lancet, said that in treating AIDS, the use of 'cocktail therapy' in combination with antibiotics could lower the mortality rate within a certain period of AIDS patients.

SMZ antibiotics are widely used for many years, prices are low.

The use of combination SMZ antibiotics with 'cocktail therapy' (powerful antiretroviral therapy), can lower the mortality rate for AIDS patients.

The report said scientists investigated 3,179 AIDS patients in Uganda and Zimbabwe.

These patients had a CD4 cell unit index dropped below 200μL and began receiving treatment with 'cocktail therapy.'

CD4 is an important immune cell in the human body and is also an attack target of HIV.

The unit index is one of the criteria for calculating a patient's immune function. The CD4 cell unit index falls below 200μL, meaning that the person carrying the HIV virus has begun to develop the disease.

The study found that using 'cocktail therapy' simultaneously with antibiotics could help patients lower the mortality rate to 59% over a three-month period.

Thus, this finding brings positive effects to the public health career.